Navigation Links
stents Result in allergic reactions

Drug eluting stents are used in the treatment of coronary artery diseases, in which a thin polymer is coated to the coronary stent and it contains the medicine// which can prevent scar formation during surgery or other intervention, in which the stent without surgery introduces drug.

Sirolimus is the commercially available drug eluting stent which reduces the chances of developing restonsis. These commercial stents are used in removing blood clots in the arteries without surgical method and reduce the chances of future heart attacks. But researchers feel that there is an increased risk of developing allergic reactions due to the use of these stents. The allergic reaction is found to be caused by the plastic material used in the stents which may be the cause of allergic reactions. The researchers feel that the risk of allergy due to the plastic can be reduced by using metal stents or conventional surgeries.

'"/>




Page: 1

Related medicine news :

1. Expandable metal stents used in digestive cancers
2. Drug-coated heart stents under scrutiny, after study
3. Hormone Deficiency Results In Miscarriage
4. Patients Pressure Would Result In Overprescription
5. Traffic Violations Result in Safer Drivers
6. Breast Implants May Interfere With The Interpretation Of Mammogram Results
7. DNA Testing For More Accurate Results
8. Abuse in Childhood Could Result In Heart Disease in Adulthood
9. Heavy Computer Use May Result In Glaucoma
10. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
11. Marijuana Use Could Result In Psychosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... According to a new ... invalid because it does not obey the rules Congress has directed the CBO to ... which the GOP reform would restore. Yet, it estimates a reduction in employer-based coverage ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents ... June 9--24, 2017. This sacred and spiritual journey during the Summer Solstice ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will ... The majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... 24, 2017 , ... Empower Brokerage, located in Southlake, Texas, ... programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” program ... to teach how to maximize their sales efforts, as well as how to ...
(Date:3/24/2017)... ... ... “Vintage and Harvest A Cultivation of Christian Love” is the creation of published ... with his wife, Anna Marie. He and his wife are the proud parents of ... author of “Shadow and Substance.” , “Love, the agape kind, is seen as more ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology: